Community outbreak of macrolide-resistant mycoplasma pneumoniae in Yamagata, Japan in 2009

Pediatric Infectious Disease Journal

Volumn 32, Issue 3, 2013, Pages 237-240

  Suzuki, Yu ^a   Itagaki, Tsutomu ^b   Seto, Junji ^a   Kaneko, Akiko ^a   Abiko, Chieko ^a   Mizuta, Katsumi ^a   Matsuzaki, Yoko ^b  

^a YAMAGATA UNIVERSITY   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

Author keywords

23SrRNA; Macrolide resistance; Mycoplasma pneumoniae; School based outbreak

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; MINOCYCLINE; NORFLOXACIN; RNA 23S; ROKITAMYCIN;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GENETICS; BACTERIAL MUTATION; BACTERIUM CULTURE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHILD; EPIDEMIC; GENE MUTATION; HIGH SCHOOL STUDENT; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MYCOPLASMA PNEUMONIA; PRIORITY JOURNAL; SCHOOL CHILD; THROAT CULTURE;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; COMMUNITY-ACQUIRED INFECTIONS; DISEASE OUTBREAKS; DNA, BACTERIAL; DNA, RIBOSOMAL; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; JAPAN; MACROLIDES; MALE; MICROBIAL SENSITIVITY TESTS; MYCOPLASMA PNEUMONIAE; PHARYNX; PNEUMONIA, MYCOPLASMA; POINT MUTATION; RNA, RIBOSOMAL, 23S; SEQUENCE ANALYSIS, DNA;

EID: 84876292959     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31827aa7bd     Document Type: Article

References (30)

1. Waites KB, Talkington DE Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004;17:697-728.
2. Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev. 2008;32:956-973.
3. Foy HM. Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients. Clin Infect Dis. 1993;17(suppl 1):S37-S46.
4. Block S, Hedrick J, Hammerschlag MR, et al. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethyl-succinate. Pediatr Infect Dis J. 1995;14:471-477.
5. Korppi M, Heiskanen-Kosma T, Kleemola M. Incidence of community-acquired pneumonia in children caused by Mycoplasma pneumoniae: serological results of a prospective, population-based study in primary health care. Respirology. 2004;9:109-114.
6. Peuchant O, Ménard A, Renaudin H, et al. Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis. J Antimicrob Chemother. 2009;64:52-58.
7. Dumke R, von Baum H, Lück PC, et al. Occurrence of macrolide-resist-ant Mycoplasma pneumoniae strains in Germany. Clin Microbiol Infect. 2010;16:613-616.
8. Chironna M, Sallustio A, Esposito S, et al. Emergence of macrolide-resist-ant strains during an outbreak of Mycoplasma pneumoniae infections in children. J Antimicrob Chemother. 2011;66:734-737.
9. Yamada M, Buller R, Bledsoe S, et al. Rising rates of macrolide-resistant Mycoplasma pneumoniae in the central United States. Pediatr Infect Dis J. 2012;31:409-400.
10. Liu Y, Ye X, Zhang H, et al. Characterization of macrolide resistance in Mycoplasma pneumoniae isolated from children in Shanghai, China. Diagn Microbiol Infect Dis. 2010;67:355-358.
11. Okazaki N, Narita M, Yamada S, et al. Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro. Microbiol Immunol. 2001;45:617-620.
12. Morozumi M, Iwata S, Hasegawa K, et al.; Acute Respiratory Diseases Study Group. Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia. Antimicrob Agents Chemother. 2008;52:348-350.
13. Morozumi M, Takahashi T, Ubukata K. Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia. J Infect Chemother. 2010;16:78-86.
14. Ubukata K, Morozumi M, Iwata S. Large epidemic of Mycoplasmal pneumonia caused by Mycoplasma pneumoniae strains highly resistant to mac-rolides among children in 2011. IASR. 2011;32:337-339. In Japanease.
15. Pereyre S, Guyot C, Renaudin H, et al. In vitro selection and characterization of resistance to macrolides and related antibiotics in Mycoplasma pneumoniae. Antimicrob Agents Chemother. 2004;48:460-465.
16. Matsuoka M, Narita M, Okazaki N, et al. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob Agents Chemother. 2004;48:4624-4630.
17. Morozumi M, Hasegawa K, Kobayashi R, et al. Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23 S rRNA gene mutation. Antimicrob Agents Chemother. 2005;49:2302-2306.
18. Suzuki S, Yamazaki T, Narita M, et al. Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae. Antimicrob Agents Chemother. 2006;50:709-712.
19. Dominguez A, Minguell S, Torres J, et al. Community outbreak of acute respiratory infection by Mycoplasma pneumoniae. Eur J Epidemiol. 1996;12:131-134.
20. Walter ND, Grant GB, Bandy U, et al. Community outbreak of Mycoplasma pneumoniae infection: school-based cluster of neurologic disease associated with household transmission of respiratory illness. J Infect Dis. 2008;198:1365-1374.
21. Pereyre S, Renaudin H, Charron A, et al. Clonal spread of Mycoplasma pneumoniae in primary school, Bordeaux, France. Emerging Infect Dis. 2012;18:343-345.
22. Hyde TB, Gilbert M, Schwartz SB, et al. Azithromycin prophylaxis during a hospital outbreak of Mycoplasma pneumoniae pneumonia. J Infect Dis. 2001;183:907-912.
23. Wang Y, Qiu S, Yang G, et al. An outbreak of Mycoplasma pneumoniae caused by a macrolide-resistant isolate in a nursery school in China. Antimicrob Agents Chemother. 2012;56:3748-3752.
24. Cao B, Zhao CJ, Yin YD, et al. High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China. Clin Infect Dis. 2010;51:189-194.
25. Lin C, Li S, Sun H, et al. Nested PCR-linked capillary electrophoresis and single-strand conformation polymorphisms for detection of macrolide-resistant Mycoplasma pneumoniae in Beijing, China. J Clin Microbiol. 2010;48:4567-4572.
26. Ieven M, Ursi D, Van Bever H, et al. Detection of Mycoplasma pneumoniae by two polymerase chain reactions and role of M. pneumoniae in acute respiratory tract infections in pediatric patients. J Infect Dis. 1996;173:1445-1452.
27. Dorigo-Zetsma JW, Wilbrink B, van der Nat H, et al. Results of molecular detection of Mycoplasma pneumoniae among patients with acute respiratory infection and in their household contacts reveals children as human reservoirs. J Infect Dis. 2001;183:675-678.
28. Kamizono S, Ohya H, Higuchi S, et al. Three familial cases of drug-resistant Mycoplasma pneumoniae infection. Eur J Pediatr. 2010;169:721-726.
29. Wolff B J, Thacker WL, Schwartz SB, et al. Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis. Antimicrob Agents Chemother. 2008;52:3542-3549.
30. Li X, Atkinson TP, Hagood J, et al. Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates. Pediatr Infect Dis J. 2009;28:693-696.